Literature DB >> 19910889

Immunopathogenesis of ovarian cancer.

M S Thompson1, S C Mok.   

Abstract

Immune cells in the ovarian stromal microenvironment play an important role in ovarian tumorigenesis. Up-regulation of immune cell-derived mediators during ovulation may generate a proinflammatory niche, which may subsequently induce transformation of normal ovarian epithelial cells or endometriotic cells in the ovary. Once transformed ovarian epithelial cells develop, an immunoediting process occurs in which immune cells and their mediators dictate the development and progression of ovarian tumors. Tumor cells also develop several mechanisms to evade anti-tumor immunity by developing an immunosuppressive microenvironment. The differences in the population of immune cells infiltrating into ovarian tumor tissues are associated with differences in clinical outcomes. The underlying molecular mechanisms of the association begin to unravel with the development of microdissection techniques, high throughput technologies, in vitro functional assays, and in vivo mouse modeling. A better understanding of the complex relationship between ovarian tumor cells and the associated immune cells will allow us to develop novel immunologic strategies for ovarian cancer prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910889

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  6 in total

1.  FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.

Authors:  Wei Wei; Samuel C Mok; Esther Oliva; Sung-hoon Kim; Gayatry Mohapatra; Michael J Birrer
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

2.  Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy.

Authors:  Hans Bösmüller; Sophie Haitchi-Petnehazy; Gerald Webersinke; Renate Marschon; Franz Roithmeier; Wolfgang Stummvoll; Tanja Fehm; Margit Klier-Richter; Irina Bonzheim; Annette Staebler; Falko Fend
Journal:  Virchows Arch       Date:  2011-06-29       Impact factor: 4.064

Review 3.  Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.

Authors:  J Krzystyniak; L Ceppi; D S Dizon; M J Birrer
Journal:  Ann Oncol       Date:  2016-04       Impact factor: 32.976

Review 4.  Ovarian cancer: genomic analysis.

Authors:  W Wei; D Dizon; V Vathipadiekal; M J Birrer
Journal:  Ann Oncol       Date:  2013-12       Impact factor: 32.976

5.  Epithelial ovarian cancer inherent resistance: May the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role?

Authors:  Antonio Simone Laganà; Vincenza Sofo; Salvatore Giovanni Vitale; Onofrio Triolo
Journal:  Gynecol Oncol Rep       Date:  2016-09-19

6.  ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment.

Authors:  Chi-Lam Au-Yeung; Tsz-Lun Yeung; Abhinav Achreja; Hongyun Zhao; Kay-Pong Yip; Suet-Ying Kwan; Michaela Onstad; Jianting Sheng; Ying Zhu; Dodge L Baluya; Ngai-Na Co; Angela Rynne-Vidal; Rosemarie Schmandt; Matthew L Anderson; Karen H Lu; Stephen T C Wong; Deepak Nagrath; Samuel C Mok
Journal:  Nat Commun       Date:  2020-07-15       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.